State Street’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Sell |
2,795,090
-56,076
| -2% | -$475K | ﹤0.01% | 2096 |
|
|
2025
Q1 | $22.9M | Sell |
2,851,166
-66,873
| -2% | -$538K | ﹤0.01% | 2061 |
|
|
2024
Q4 | $26.2M | Sell |
2,918,039
-27,021
| -0.9% | -$243K | ﹤0.01% | 2064 |
|
|
2024
Q3 | $21.6M | Buy |
2,945,060
+64,949
| +2% | +$476K | ﹤0.01% | 2161 |
|
|
2024
Q2 | $16.4M | Buy |
2,880,111
+109,247
| +4% | +$624K | ﹤0.01% | 2268 |
|
|
2024
Q1 | $13.9M | Buy |
2,770,864
+66,482
| +2% | +$333K | ﹤0.01% | 2387 |
|
|
2023
Q4 | $24.3M | Buy |
2,704,382
+104,847
| +4% | +$943K | ﹤0.01% | 2104 |
|
|
2023
Q3 | $20.2M | Sell |
2,599,535
-32,951
| -1% | -$256K | ﹤0.01% | 2175 |
|
|
2023
Q2 | $25.5M | Buy |
2,632,486
+52,474
| +2% | +$508K | ﹤0.01% | 2093 |
|
|
2023
Q1 | $28.3M | Buy |
2,580,012
+130,465
| +5% | +$1.43M | ﹤0.01% | 1998 |
|
|
2022
Q4 | $10.6M | Buy |
2,449,547
+8,113
| +0.3% | +$35K | ﹤0.01% | 2658 |
|
|
2022
Q3 | $18.4M | Buy |
2,441,434
+53,572
| +2% | +$403K | ﹤0.01% | 2290 |
|
|
2022
Q2 | $24M | Buy |
2,387,862
+1,863,594
| +355% | +$18.7M | ﹤0.01% | 2123 |
|
|
2022
Q1 | $6.49M | Buy |
524,268
+144,586
| +38% | +$1.79M | ﹤0.01% | 3049 |
|
|
2021
Q4 | $8.68M | Buy |
379,682
+4,944
| +1% | +$113K | ﹤0.01% | 2988 |
|
|
2021
Q3 | $8.29M | Buy |
+374,738
| New | +$8.29M | ﹤0.01% | 2985 |
|